Susan E Bergeson

Title: Innovations by Susan E. Bergeson

Introduction

Susan E. Bergeson is an accomplished inventor based in Lubbock, Texas. She has made significant contributions to the field of medical treatments, particularly in addressing alcohol use disorder and other inflammatory conditions. With a total of two patents to her name, her work is recognized for its innovative approach to treatment.

Latest Patents

Bergeson's latest patents focus on a modified tetracycline for the treatment of alcohol use disorder, pain, and other disorders involving potential inflammatory processes. The method involves providing a subject with an effective amount of a modified tetracycline or its derivative to ameliorate or eliminate conditions such as Alcohol Use Disorder (AUD), Substance Use Disorder (SUD), tobacco use, pain, or proinflammatory disorders. The modified tetracycline has reduced binding to a microbial ribosome and is characterized by a specific chemical formula where R1 is acetyl, R2 is OH or acetyl, R3 is acetyl, R4 is H or acetyl, and R5 is acetyl.

Career Highlights

Bergeson is affiliated with the Texas Tech University System, where she continues her research and development in innovative medical treatments. Her work has garnered attention for its potential to improve the quality of life for individuals suffering from various disorders.

Collaborations

Some of her notable coworkers include Peter Syapin and Ted W. Reid, who have collaborated with her on various projects within the Texas Tech University System.

Conclusion

Susan E. Bergeson's contributions to medical innovation highlight her dedication to improving treatment options for complex disorders. Her patents reflect a commitment to advancing healthcare through scientific research and collaboration.